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The use of oligonucleotides to activate
selected exons is hampered by a poor un-
derstanding of the mechanisms of
splicing enhancers. In this study, Smith
et al. show that a bifunctional oligonucle-
otide enhancer of splicing of SMN2 exon
7 stimulates recruitment of U2 snRNP to
the upstream intron. Surprisingly, the
GGA-rich enhancer forms a quadruplex
and complexes enriched in hnRNP H
and other proteins. Nonetheless, these
complexes do not prevent enhancer ac-
tivity, suggesting that SR proteins func-
tion here via dynamic exchange.
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The use of oligonucleotides to activate the splicing of
selected exons is limited by a poor understanding of
the mechanisms affected. A targeted bifunctional
oligonucleotide enhancer of splicing (TOES) anneals
to SMN2 exon 7 and carries an exonic splicing
enhancer (ESE) sequence.We show that it stimulates
splicing specifically of intron 6 in the presence of re-
pressing sequences in intron 7. Complementarity to
the 50 end of exon 7 increases U2AF65 binding, but
the ESE sequence is required for efficient recruitment
of U2 snRNP. The ESE forms at least three coexisting
discrete states: a quadruplex, a complex containing
only hnRNP F/H, and a complex enriched in the
activator SRSF1. Neither hnRNP H nor quadruplex
formation contributes to ESE activity. The results
suggest that splicing limited by weak signals can
be rescued by rapid exchange of TOES oligonucleo-
tides in various complexes and raise the possibility
that SR proteins associate transiently with ESEs.INTRODUCTION
Pre-mRNA splicing has the potential to be a target of consider-
able importance for therapeutic intervention. Most human
protein-coding genes express two or more spliced isoforms
of mRNA at significant levels, conferring additional diversity
and flexibility to the informational capability of a limited number
of genes (Djebali et al., 2012; Pan et al., 2008; Wang et al.,
2008). Moreover, recent reports suggest that splicing might be
stochastic, i.e., that the use of a particular exon or splice site is
a matter of probability and that many minor alternative events
might arise as stochastic noise (Djebali et al., 2012; Melamud
and Moult, 2009). If splicing patterns are not fixed, it may befeasible to redirect almost any splicing pattern for therapeutic
purposes.
One of the most successful techniques for redirecting the
splicing patterns of specific genes is to use oligonucleotides
complementary to splicing signals or auxiliary motifs in the pre-
mRNA (Eperon, 2012; Rigo et al., 2012; Singh and Cooper,
2012). These techniques were first designed to suppress the
use of a particular pattern by blocking the binding of splicing fac-
tors to splice sites or exons (Dominski and Kole, 1993; Mayeda
et al., 1990) and were subsequently developed as potential ther-
apies for muscular dystrophy in cases where skipping of an exon
carrying a nonsense mutation would be beneficial (Cirak et al.,
2011; Dunckley et al., 1998; Goemans et al., 2011). The develop-
ment of oligonucleotides that had the opposite effect, stimu-
lating exon splicing, followed from the discovery of exonic
splicing enhancers (ESEs). ESE sequences in the exons of
normal pre-mRNA are bound by activator proteins, the best
characterized of which are the SR proteins. These proteins
contain one or two RNA-binding domains and a C-terminal
domain rich in RS dipeptides. The C-terminal domain of an
ESE-bound SR protein was proposed to interact directly with
the 30 splice site-recognition factor, U2AF, the recruitment of
which is often a limiting step in splicing, thereby increasing the
level of binding of U2AF (Graveley et al., 2001; Lavigueur et al.,
1993; Staknis and Reed, 1994; Wang et al., 1995; Wu and Mani-
atis, 1993). This led to the development of two types of oligonu-
cleotides to stimulate usage of an exon. In one version, a PNA
sequence complementary to a target exon is attached to a short
RS domain peptide (Cartegni and Krainer, 2003). In the other,
an oligonucleotide complementary to a target exon is extended
by an ESE sequence (Skordis et al., 2003). These bipartite
oligonucleotides are referred to as targeted oligonucleotide
enhancers of splicing (TOES) (Eperon and Muntoni, 2003). Other
sequences in or around exons have been found to act as
silencers, and in such cases activation can also be achieved
by using oligonucleotides to block the binding of repressor pro-
teins (Hua et al., 2007, 2008).Cell Reports 9, 193–205, October 9, 2014 ª2014 The Authors 193
Figure 1. Inhibition of Splicing of SMN2
Exon 7 by Intron 7 Sequences and Activation
by GGA
(A) Sequence of the TOES oligonucleotide GGA
(AD, annealing domain; ED, ESE domain) annealed
to SMN2 exon 7 (lowercase, intron; uppercase,
exon [with the portion omitted shown by the dotted
line]; red, site of the C/U difference in SMN1 versus
SMN2; blue, exonic enhancer).
(B) Effects of oligonucleotides at 250 nMon the time
courses of splicing in vitro of the introns 50 and 30 of
exon 7 (SMN2) in SMN2/b-globin chimeric sub-
strates (Owen et al., 2011; Skordis et al., 2003). The
substrate in the right-hand panel included 122 nt of
intron 6 preceding exon 7. NO, no oligonucleotide.
(C) Effects of increasing lengths of SMN2 intron 7
on the response of a b-globin/SMN2 exon 7
chimeric substrate to GGA and AD oligonucleo-
tides. In vitro splicing assays were done in tripli-
cate for 2 hr with oligonucleotides at 250 nM. Error
bars show the SDs of the triplicates.One of the difficulties in designing oligonucleotides that mimic
the actions of ESEs and SR proteins is that the mechanisms of
activation by the latter are still poorly understood (Eperon,
2012). In addition to the recruitment of U2AF to weak 30 splice
sites, the RS domains of ESE-bound SR proteins have also
been shown to stabilize RNA duplexes formed between the 50
splice site and branchpoint sequences with U6 and U2 snRNA,
respectively (Shen and Green, 2006). One SR protein, SRSF1,
enhances U1 snRNP binding to the 50 splice site via protein inter-
actions of its RRM domains (Cho et al., 2011). It is possible that
some of these interactions may not be direct, since the introduc-
tion of a non-RNA linker between an ESE and a target 50 splice
site was shown to prevent ESE activity in vitro (Lewis et al.,
2012), and not all of the interactions may be involved at every
ESE or made by every SR protein. Therefore, it is difficult to
identify the deficiencies in an exon’s splicing signals and the
best ways to compensate for them.
TOES oligonucleotides have been used to activate exons in
SMN2 (Skordis et al., 2003; Marquis et al., 2007; Baughan
et al., 2009), Ron (Ghigna et al., 2010), and IKBKAP (Ibrahim
et al., 2007). Important determinants of the prototypical
TOES oligonucleotide-activating SMN2 exon 7 include its
site of annealing in the exon, the number of ESE-type motifs,
and the inclusion of a non-RNA linker between the domains
(Owen et al., 2011; Perrett et al., 2013). Surprisingly, previous194 Cell Reports 9, 193–205, October 9, 2014 ª2014 The Authorswe found that it augmented splicing
equally effectively even in the absence
of an ESE in exon 7 (Owen et al., 2011)
that is otherwise essential (Hofmann
et al., 2000; Martins de Arau´jo et al.,
2009), the sites of annealing that enabled
efficient activation of SMN2 exon 7 were
very restricted, and stabilizing the anneal-
ing of the oligonucleotide with modified
nucleotides reduced its activity (Owen
et al., 2011). These findings suggest that
the mechanistic models used as a basisfor designing the oligonucleotides were inadequate, which com-
promises our ability to apply TOES oligonucleotides to rescue
other exons. Consequently, we investigated the mechanisms
by which the two domains of the oligonucleotide contribute to
splicing activation.
RESULTS
Identification of Sequences that Suppress Exon 7
Splicing and Are Counteracted by GGA
The most effective TOES oligonucleotides tested on SMN2
anneal to exon 6 or 7 and contain three repeats of the sequence
GGAGGAC in the ESE portion (Owen et al., 2011). Here, we focus
on an oligonucleotide, termed GGA, that anneals to exon 7
(Figure 1A). This stimulates inclusion of exon 7 both in vitro and
in fibroblasts derived from patients (Skordis et al., 2003); in the
latter case, SMN protein expression is elevated for more than
28 days after a second transfection of cells with the oligonucle-
otide (Owen et al., 2011).
The standard pre-mRNA used to test the activity of TOES
oligonucleotides contains SMN2 exon 7 and adjacent intron
sequences flanked by portions of introns and exons of b-globin.
The effects of TOES oligonucleotides on this pre-mRNA were
previously shown to correlate well with those on the endogenous
SMN2 gene in patient fibroblasts (Owen et al., 2011). To identify
Figure 2. Effects of GGA and AD on U2AF65
Recruitment
(A) Effect of the GGA oligonucleotide on proteins
crosslinking to SMN2 exon 7 in nuclear extracts.
32P-uridine-labeled RNA comprising SMN2 exon 7
flanked by the 30 41 nt of intron 6 and the 50 58 nt of
intron 7 was incubated in nuclear extracts from
HeLa or 293T cells with 250 nM GGA. UV irradia-
tion and RNase treatment were followed by SDS-
PAGE and transfer to nitrocellulose. The positions
of molecular weight markers are shown. The
asterisk marks a band that increased in intensity
when GGA was present.
(B) Effects of GGA or AD oligonucleotides on
crosslinking of the SMN2 substrate to a protein
that migrates with U2AF65. TM1 is a tropomyosin
exon-based RNA that crosslinks very efficiently
to PTB (Cherny et al., 2010), but at 250 mM KCl
the PTB signal is reduced and a U2AF65 band
just above it is detectable. After exposure, the
membrane was incubated with antibodies to
detect U2AF65. The U2AF bands coincide with the
radioactive band marked with an asterisk.
(C) Immunoprecipitation after crosslinking with
anti-U2AF65. IP, total crosslinked mixture as in
(A) and (B); Ab, procedures done in the absence
of antibody.the splicing reactions stimulated by GGA, we tested transcripts
containing single introns. The results (Figure 1B) showed that
there was little stimulation of splicing. One possible explanation
for this is that GGA is active when exon 7 is flanked by both
introns 6 and 7. To test this, various lengths of a second intron
were incorporated into the transcripts. GGA had little effect on
splicing when exon 7 was preceded by the proximal 122 nt of
intron 6 (Figure 1B). However, extending the length of intron 7
incorporated to the 30 side of exon 7 progressively reduced the
efficiency of splicing and GGA substantially counteracted this
effect (Figure 1C): an oligonucleotide containing only the anneal-
ing domain (AD) had less effect than GGA, but still enhanced
splicing slightly. We conclude that GGA counteracts the inhibi-
tory effects of intron 7 on the splicing of intron 6.
Effects of the AD of GGA on ATP-Independent Binding
of U2AF65
These results suggest that the oligonucleotide overcomes a
limiting step in spliceosome assembly imposed in part by se-
quences in intron 7. Early steps of assembly involve the binding
of factors at the 50 and 30 splice sites, which can be studied inde-
pendently of subsequent events if ATP is omitted. The first factor
known to bind specifically to 50 splice sites is the U1 snRNP
(Roca et al., 2013). Neither psoralen crosslinking nor immuno-
precipitation revealed any effects of the oligonucleotide on
the binding of U1 snRNP to the 50 splice site of intron 7 (data
not shown). The binding of protein factors was analyzed by UVCell Reports 9, 193–20crosslinking to a radiolabeled transcript
comprising exon 7 flanked by 41 nt of
intron 6 and 58 nt of intron 7. GGA and
AD increased the levels of crosslinkingto a band of 50–75 kDa, detected after transfer of the proteins
onto a nitrocellulose filter (Figures 2A and 2B). Comparison
with PTB crosslinked to a TPM1 substrate (Cherny et al., 2010)
showed that the band comigrated with U2AF65, a protein
required for the assembly of early splicing complexes that binds
to 30ss polypyrimidine tracts. Moreover, the radioactivity from
crosslinking coincided perfectly with the chemiluminescent
signal that arose from immunodetection of U2AF65 on the
same filter (Figure 2B). Finally, immunoprecipitation of U2AF65
confirmed in both of two trials that GGA and, to a lesser extent,
AD increased U2AF65 crosslinking to the transcript (Figure 2C).
We conclude that GGA and AD facilitate the binding of U2AF65
to the 30ss of intron 6.
Effects of the ESE Domain of GGA on the Formation of
ATP-Dependent Complexes
We analyzed later stages of assembly by detecting heparin-
resistant complexes that formed on the same exon 7-based
transcript in the presence of ATP. GGA strongly promoted the
assembly of a U2-dependent complex (ED-A; Figures 3A and
3B) and base-pairing of U2 snRNA to the transcript (Figure 3C).
Oligonucleotide AD had a much smaller effect. A 20-O-methyl
oligonucleotide complementary to the 50 end of U1 snRNA
reduced ED-A formation, showing that U1 snRNP also contrib-
uted to assembly (data not shown). When we analyzed complex
assembly on the intron 6-based transcript with 80 nt of intron 7 to
the 30 side (Figure 1C), we found that GGA stimulated assembly5, October 9, 2014 ª2014 The Authors 195
Figure 3. Effects of GGA and AD on Assem-
bly of U2 snRNP-Containing Complexes
(A) Time courses of complex assembly in nuclear
extract containing ATP on SMN2 exon 7 flanked
by intron sequences as shown. As in Figure 2, GGA
or AD oligonucleotides were included at 250 nM
as shown; bG is a pre-mRNA derived from
b-globin. The levels of radiolabeled RNA in the
absence of oligonucleotide are usually much
reduced, possibly due to degradation of RNA that
does not enter spliceosome-related complexes.
ED-A marks the exon-defined complex A.
(B) Effects on complex assembly of preincubation
of extract with DNA oligonucleotides directing
RNase H degradation at two sites of U2 snRNA.
(C) Psoralen-mediated crosslinking of radio-
labeled SMN2 exon 7 substrate incubated in nu-
clear extract with GGA and/or oligonucleotides
directing degradation of U2 snRNA. Adducts
crosslinked to the substrate are indicated. The
band labeled as U2* is presumed to be U2 snRNA
that was cut only at the 50 end and was still able
to associate with the substrate.
(D) Stimulation by GGA of spliceosome assembly
on pre-mRNA comprising b-globin exon 2/SMN2
exon 7 with 80 nt of intron 7 to the 30 side.of the prespliceosome (complex A) and spliceosomal complexes
(Figure 3D). We conclude that whereas the AD is sufficient to
stimulate binding of U2AF65 to the 30 splice site of intron 6, the
ESE domain of GGA stimulates the recruitment of U2 snRNPs
and the assembly of complex A and spliceosomes.
Affinity Purification of GGA-Protein Complexes by
Photoelution and Mass Spectrometry
To identify the proteins bound to GGA, we performed conven-
tional affinity purification using a biotinylated transcript with the
same sequence as GGA that had been incubated in nuclear
extract. Proteins were separated by gel electrophoresis and
bands were analyzed by mass spectrometry (MS). This revealed
about eight major proteins and a number of proteins that were
less abundant (data not shown). The most abundant proteins
included hnRNP U, DHX36, nucleolin, hnRNP F/H, hnRNP A1,
and CNBP, but not SRSF1. The high number of proteins recov-
ered suggested that the transcript was forming heterogeneous
complexes. One likely reason for this was that the concentration
of the oligonucleotide was too high relative to the availability
and affinity of specific proteins. Another possibility was that
specific proteins, such as SRSF1, dissociated during purifi-
cation and were replaced by other proteins. Native gel electro-
phoresis was used to test whether heterogeneous complexes
formed (Figures S1A and S1B). A discrete complex formed in
low concentrations of nuclear extract or in the presence of
heparin, and several larger complexes formed in higher con-
centrations of nuclear extract and in the absence of heparin.
We conclude that there is a core complex of tightly bound196 Cell Reports 9, 193–205, October 9, 2014 ª2014 The Authorsproteins formed on the ESE domain that
is augmented or replaced by additional
proteins in functional splicing conditions.To establish that the isolated proteins came from the core
complex, we sought a method that would enable intact com-
plexes to be purified, eluted in native conditions, and analyzed
by native gel electrophoresis. Moreover, it was important to iden-
tify the proteins that were associated with the full functional
oligonucleotide but bound to the ESE domain. For this purpose,
we performed affinity purification and photocleavage (Figure 4A).
Complexes assembled on GGA were captured on avidin beads
via a 30 biotin adduct, and the ED complex was selectively eluted
by cleavage of a photosensitive linkage between the AD and
ED (Figures 4A and 4B). The biotinylated and photocleavable
oligonucleotide assembled complexes similar to those formed
onGGA, and cleavage after retention on avidin-agarose released
a complex that comigrated with the complex formed on the ED
(Figure S1C). Moreover, the photocleavable oligonucleotide
stimulated exon 7 inclusion in splicing assays, and irradiation
during the reaction reduced its efficacy (Figures S1D and S1E).
MS on the proteins eluted after photocleavage produced a list
of 41 proteins that were not in the control sample (Table S1).
These were ranked based on the intensities of the top three pep-
tides of each protein (Silva et al., 2006). The abundant proteins
were clustered by relative molecular mass (Mr) into four groups:
(1) a high-Mr group comprising helicase DHX36, exonuclease
XRN2, nucleolin, and hnRNP U; (2) hnRNP F/H; (3) hnRNP A1
and SR proteins; and (4) CNBP. The proteins most likely to be
responsible for the activity of the ESE domain in stimulating the
recruitment of U2 snRNP and assembly of complex A are the
SR proteins. Of these, SRSF1 was ranked most highly by MS
(9th of 41 proteins), whereas the next most abundant, SRSF2,
Figure 4. Binding of Proteins to the ESE
Domain of GGA
(A) Strategy for selection by photoelution of
proteins binding to the ED after assembly on the
intact functional oligonucleotide GGA-PC-bio.
Pc, photocleavable linkage; circle, biotin; gray,
avidin beads; lightning bolt, irradiation with long-
wave UV.
(B) Diagram of GGA-PC-bio.
(C) Crosslinking by short-wave UV to 50 end-
labeled ED in HEK293T extracts, followed by
immunoprecipitation with anti-SRSF1 (left) or anti-
hnRNP F/H (right). Phosphorimager profiles of
the input (gray lines) and precipitated reactions
(black lines) are shown from parallel gel lanes in
each experiment. Ordinate, digital light units,
arbitrary linear scale; abscissa, distance migrated,
on an arbitrary linear scale with the origin on the
left. Control lanes (minus antibody and minus
irradiation) were blank in both experiments. The
ordinate scale of the immunoprecipitations was
expanded for visual comparison; for example, the
signal from the immunoprecipitated SRSF1 was
approximately 3% of the signal predicted from the
input intensity.
(D) Crosslinking as in (C), without immunopre-
cipitation. Lanes 1–4 show results from one gel of
crosslinking in functional nuclear extracts from
cells transfected with siRNAs complementary to
hnRNP H or F and H, as shown, or expressing
GFP-hnRNP H; an intervening lane is not shown.
Lanes 5–7 show results of crosslinking in extracts
prepared from cells expressing T7-CNBP and
GFP-SRSF1. The labels to the right indicate
the identities of major components of each band.
The bands in between the high-Mr proteins and
hnRNP F/H correspond to GFP fusion proteins, as
indicated.
See also Figure S1 and Tables S1 and S2.ranked only 25th. The ESE domain was designed to recruit
SRSF1, which is known to bind GGA motifs with high affinity
(Tacke and Manley, 1995; Sanford et al., 2009; Cho et al.,
2011; Cle´ry et al., 2013; Pandit et al., 2013; Ray et al., 2013),
and we previously showed that recombinant SRSF1 is able to
bind it specifically (Owen et al., 2011). The hnRNP proteins F
and H bind G-triplets, and especially GGGA (Caputi and Zahler,
2001; Dominguez et al., 2010). G-triplets are generally found
in introns, where they are associated with the stimulation of
splicing by hnRNP H (Chou et al., 1999; Han et al., 2005; McCul-
lough and Berget, 1997; Xiao et al., 2009). They are generally
considered to be uncommon and associated with inhibition
when found in exons (Chen et al., 1999; Lim et al., 2011; Mauger
et al., 2008), although other findings suggest that sites within
exons can also activate inclusion by recruiting hnRNP H (Caputi
and Zahler, 2002; Huelga et al., 2012). The other groups ofCell Reports 9, 193–20proteins are not generally considered
to be splicing factors. Nucleolin, CNBP,
and DHX36 are all associated with
G-quadruplexes: CNBP binds single-
stranded purine-rich sequences, such asGGA (Armas et al., 2008; Liu et al., 1998b; Michelotti et al.,
1995), and promotes the formation of parallel G-quadruplexes
(Borgognone et al., 2010); nucleolin binds and stabilizes parallel
G-quadruplexes (Bates et al., 1999; Gonza´lez et al., 2009); and
DHX36 binds tightly to G-quadruplexes and promotes unwinding
(Creacy et al., 2008; Giri et al., 2011; Vaughn et al., 2005).
Different Sets of Proteins Contact the ESE Domain
To test for the presence of a common core complex, we incu-
bated end-labeled ED at low nanomolar concentrations in
nuclear extract and proteins crosslinked to it by short-wave
UV. Potential components of the complex were immunopre-
cipitated. Since there was no treatment with ribonuclease, we
expected that all of the crosslinked proteins would be detected
in constant ratios regardless of the antigen selected if there
were a single discrete complex. Without immunoprecipitation,5, October 9, 2014 ª2014 The Authors 197
crosslinking showed, as expected, that the ED was in contact
with the proteins of 100, 50, 35, and 20 kDa, allowing for
the mass of the attached oligonucleotide (Figures 4C and 4D).
Similar results were found with 50 end-labeled GGA attached
to a photoreactive aryl azide and irradiated with long-wave
UV (data not shown). However, immunoprecipitation with anti-
bodies to SRSF1 and hnRNP F/H produced different patterns,
demonstrating that there are different discrete complexes
(Figure 4C). With anti-SRSF1, the high-Mr proteins were absent
and the levels of hnRNP F/H and CNBP crosslinking were
reduced 4-fold relative to SRSF1 (Figure 4C); with anti-hnRNP
F/H, none of the 100 kDa, 30 kDa, or 20 kDa crosslinked
proteins were recovered. This shows that in the majority of
oligonucleotides where it was bound, hnRNP F/H excluded
other proteins from making crosslinks to the RNA. In contrast,
binding by SRSF1 was incompatible with high-Mr proteins, but
not with hnRNP F/H or CNBP. The incompatibility of binding
by SRSF1 with binding by DHX36 and nucleolin could be ex-
plained if the binding of the latter two proteins, unlike hnRNP
F/H or CNBP, required the entire ESE domain. Alternatively,
the oligonucleotide itself might exist in at least two different
conformations: one bound by high-Mr proteins and one bound
by hnRNP F/H, SRSF1, and CNBP in competition. The exis-
tence of competition among the high-Mr proteins, hnRNP
F/H, and SRSF1 was tested by depletion of hnRNP F/ H by
RNAi or overexpression of GFP-hnRNP H or GFP-SRSF1 (Fig-
ure 4D). The levels of crosslinking to hnRNP F/H were inversely
correlated with those of crosslinking to the high-Mr proteins
and SRSF1 (Table S2).
Formation of G-Quadruplexes by the ESE Domain
Since nucleolin and DHX36 bind quadruplexes, whereas the
binding of hnRNP F/H is prevented by quadruplex formation
(Samatanga et al., 2013), quadruplex formation could account
for at least part of the heterogeneity. The ESE domain of GGA
contains three GGAGGAC repeats (50-AGGAGGACGGAGGAC
GGAGGACA) (Owen et al., 2011). We synthesized the 23-mer
as RNA and its 20-OMe and 20-OMe/PS derivatives, together
with a truncated version, as a 15-mer RNA. Analysis by 1H
NMR at 800MHz in 90%H2O solution (Figure 5A) identified imino
proton resonances at high ppm values (>9 ppm) that are charac-
teristic of hydrogen-bonded NHs. All four natural and 20-OMe
RNA sequences also revealed a set of imino-NH resonances
between 11 and 12 ppm. These are consistent with the existence
of G-tetrads in a quadruplex. The poor resolution of these NH
resonances in the 23-mers likely arises from the existence of
multiple different quadruplex folds produced by the six GG
motifs. Correspondingly, the spectrum of the 15-mer ESE with
four GG motifs is better resolved.
The NMR data were confirmed by far-UV circular dichroism
(CD) spectra (Figure 5B), which show the characteristic features
of a stable, parallel folded, quadruplex structure, with a strong
positive band at 260 nm and a weak negative band at 240 nm.
However, the RNA versions show an additional atypical
shoulder of positive ellipticity in the CD spectrum between
290 and 305 nm. In addition, thermal stability studies by CD
(at 260 nm) show significant hysteresis between the melting
and refolding curves for the RNA, but not the modified oligonu-198 Cell Reports 9, 193–205, October 9, 2014 ª2014 The Authorscleotides (Figure 5C; Table S3). The shoulder at 290–305 nm
and the hysteresis are consistent with previous reports that
GGAGG-based RNA sequences form end-to-end stacks of
two quadruplex motifs via tetrad-hexad arrangements in which
the adenosines are recruited to form the hexad and stabilize
the dimer (Liu et al., 2002; Mashima et al., 2013; Uesugi et al.,
2003). Electrospray ionization (ESI)-MS analysis of the 15-mer
and 23-mer ESEs provides strong support for the formation of
a dimeric structure (Figure 5D). To test whether the ESE domain
formed a quadruplex structure in functional conditions, we
performed primer extension assays in parallel on pure GGA
and on GGA in a nuclear extract in splicing reaction conditions
(Figure 5E). In both cases, pause sites were seen at the nucleo-
tide prior to the first two 30-GGA-50 motifs in the template, but
there was much reduced pausing prior to 30-GGC-50 motifs.
This is consistent with a model in which AGG sequences partic-
ipate in intermolecular G-quadruplexes even in nuclear extracts.
The reduced intensity of the pause prior to the 50-most AGG
sequences could be accounted for by a propensity of the dimer
to dissociate once the first of the four strands has been removed
from the quadruplex by reverse transcription.
Contributions of Complexes Lacking SRSF1
to Exon 7 Inclusion
Our results showed that there are at least two major states of the
oligonucleotide that are unlikely to contain SRSF1: a quadruplex
dimer and the predominant hnRNP F/H complex. To test
whether the quadruplex might contribute to activation of exon
7, we examined the effects of aromatic compounds that might
stabilize quadruplexes. GSA-0902 and GSA-0802 are mono-
and disubstituted quindolines, respectively, that bind DNA G-
quadruplexes (Figure S2; Boddupally et al., 2012). CD was
used to test whether these compounds stabilized the ESE RNA
quadruplexes. The ligands induced changes in the quadruplex
secondary structure of the 15-mer, but the spectra were con-
sistent with the persistence of a predominantly parallel folded
topology. The hysteresis in the melting and refolding curves
persisted in the presence of the ligands, but the midpoints
increased by 4C7C, consistent with stabilization of the
ligand-bound quadruplexes (data not shown). Splicing assays
were done in triplicate with different concentrations of the quad-
ruplex-binding reagents in the presence or absence of the GGA
oligonucleotide (Figures 6A and 6B). In the presence of GGA,
themajority of the spliced products included exon 7, but addition
of the quadruplex stabilizers produced a dose-dependent
decline in the level of inclusion. There was also a decline in the
level of inclusion in the absence of GGA, but it was proportion-
ately much smaller. We conclude that stabilizers, and therefore
probably the quadruplexes themselves, do not contribute to
and indeed compromise the activity of the bifunctional GGA
oligonucleotide.
We tested the effect of hnRNP F/H on the activity of GGA
after knockdown or overexpression of hnRNP F and H, using
the extracts assayed for crosslinking to the ED (Figure 4D). The
time courses of splicing showed very little effect on the propor-
tion of SMN2 exon 7 inclusion, whether in the presence or
absence of GGA (Figures 6C and S3), even though the reduction
in levels of hnRNP F/H by RNAi was significant (Figure 6D).
Figure 5. Formation of a Quadruplex byGGA
(A) Proton NMR spectra of the EDs synthesized
from RNA (as in GGA) and 20-OMe or phosphor-
othioate/20-OMe nucleotides. The 15-mer is a
truncated version of ED (ACGGAGGACGGAGGA).
(B) Far-UV CD spectra of ESE domains.
(C) Hysteresis in CD curves for melting and re-
folding of natural and backbone-modified ESE
sequences. Oligonucleotides were at 1–6 mM
and the temperature gradient was 3 min/0.5C
with 0.2C tolerance. Spectra were recorded in
100 mM KCl, 10 mM K2HPO4/KH2PO4 at pH 7 with
10% D2O.
(D) ESI mass spectrum of the 15-mer ESE
(4956.1 g.mol1), 150 mM NH4OAc, 10% MeOH.
(E) Primer extension on GGA in the presence or
absence of nuclear extract. Extension from a
primer annealed to the AD is shown from right to
left; the template (GGA) sequence is also shown
(50 to left).
See also Table S3.DISCUSSION
Here, we have described experiments addressing the effects of
oligonucleotides that stimulate exon inclusion on the processes
of splicing. This is important both because our findings will facil-
itate future applications of bifunctional oligonucleotides and
because these oligonucleotides provide tools for investigating
the actions of enhancers. We have shown that GGA stimulates
splicing of the upstream intron, counteracting the negative influ-
ences of intron 7. In the absence of exogenous ATP, it enhancesCell Reports 9, 193–20the formation of exon-defined complexes
and the recruitment of U2AF65, and in the
presence of ATP, it stimulates the forma-
tion of spliceosomal complexes and the
recruitment of U2 snRNP. Moreover, we
have shown that the enhancer (ESE)
domain forms several mutually exclusive
complexes in nuclear extracts and that it
forms a quadruplex.
The deficiency of splicing of SMN2
exon 7 compared with SMN1 exon 7 is
known to be caused by two sequence dif-
ferences. The major one, a C-to-T transi-
tion in nt +6 of exon 7 (Lorson et al.,
1999; Monani et al., 1999), converts a
binding site for SRSF1 (Cartegni et al.,
2006; Cartegni and Krainer, 2002) into a
site for hnRNP A1 and/or Sam68 (Ka-
shima and Manley, 2003; Kashima et al.,
2007a, 2007b; Pedrotti et al., 2010). This
results in a 2-fold reduced recruitment of
U2AF65 as well as U2 snRNP, which de-
pends on both U2AF65 and the central
Tra2b-binding enhancer in the exon (Mar-
tins de Arau´jo et al., 2009). The contribu-
tion of an ESE to U2 snRNP binding is still
generally thought to be mediated byU2AF, which is necessary and, at least in some circumstances,
sufficient for U2 snRNP recruitment via interactions with
SF3B1 (Mackereth et al., 2011; Ruskin et al., 1988; Valca´rcel
et al., 1996; Zamore and Green, 1989; Cass and Berglund,
2006; Gozani et al., 1998). However, there is also a U2AF-inde-
pendent pathway for U2 recruitment (MacMillan et al., 1997)
and ESEs can function without increasing U2AF binding (Li and
Blencowe, 1999;Mu¨hlemann et al., 2000), possibly to counteract
silencers (Zhu and Krainer, 2000). The effects of AD on U2AF65
binding may explain the strong dependence of TOES activity on5, October 9, 2014 ª2014 The Authors 199
Figure 6. Contributions of the Quadruplex
and hnRNP F/H to the Activity of GGA
(A and B) Triplicate assays of splicing in vitro of
SMN2 exon 7-containing RNA were done in the
presence or absence of 250 nM GGA. The quad-
ruplex-stabilizing molecules GSA-0820 and GSA-
0902 were dissolved in DMSO and added to the
reactions to produce the final concentrations
shown. The pre-mRNA and inclusion and exclu-
sion mRNA products are indicated. Charts to
the right of each phosphorimage show the ratio of
inclusion/exclusion of exon 7 at each of the con-
centrations tested. Error bars show the SDs of the
ratios for the triplicates.
(C) Time courses of splicing in vitro in the
nuclear extracts used in Figure 4E. The extracts
were prepared from HEK293T cells transfected
with plasmids expressing mEGFP-hnRNP F and
mEGFP-hnRNP H (+F/H) or siRNA targeting
hnRNP F and H (F/H RNAi). , mock transfection.
Reactions were done in the presence or absence
of GGA and samples taken at 0, 0, 60, and 120min.
The underlined lanes were transposed in the
image.
(D) Analysis by western blotting of the nuclear
extracts used for the experiments in Figures 4E
and 6C. Antibodies detecting hnRNP F and H and
U1A were detected by fluorescent secondary an-
tibodies. C, mock transfection; , untransfected.
See also Figures S2 and S3.the site of annealing within the exon (Owen et al., 2011), even
though on its own it has only a very small effect on splicing
even in the presence of the central ESE. GGA compensates for
both of the deficiencies caused by the C-to-T mutation and
also eliminates the dependence on the central ESE. In SMN1,
the binding of SRSF1 to the 50 end of the exon may contribute
to U2 recruitment, whereas in SMN2 the ESE domain of GGA
may provide sufficient contacts (Figure 7).
The inhibitory effect of intron 7 sequences on splicing
of intron 6 and the lack of effect of oligonucleotides on
the splicing of intron 6 in the absence of such sequences200 Cell Reports 9, 193–205, October 9, 2014 ª2014 The Authors(Figure 1) suggest that the inhibitory ef-
fect of the C-to-T mutation is established
in cooperation with intron 7 sequences.
This might reflect a failure of an exon
definition process, although exon defini-
tion currently lacks a mechanistic
description and does not necessarily
require more of the downstream intron
than a 50 splice site (Robberson et al.,
1990; Kreivi et al., 1991). A possible
explanation is that the known hnRNP
A1 binding sites in intron 7 at nt +10
to +24 (Hua et al., 2008; Singh et al.,
2006) and the SMN2-specific site at nt
100 (Kashima et al., 2007b), together
with other likely sites in the exon (Vezain
et al., 2010) and intron 7, may act in a
concerted way to repress U2 snRNPrecruitment. This may explain the need for additional contacts
even when U2AF binding is observed.
The existence of quadruplex structures in functional condi-
tions is generally difficult to establish, since they can be detected
in short, pure RNA fragments but function within a longer RNA
sequence in the presence of potential secondary structures
and RNA-binding proteins. In contrast, GGA is a discrete func-
tional unit that forms a quadruplex in isolation and also in nuclear
extracts (Figure 5), where the structure antagonizes the activity
of GGA (Figures 6A and 6B). The propensity to form quadru-
plexes may not be wholly disadvantageous. The head-to-head
Figure 7. Models for the Effects of Oligonu-
cleotides on Splicing of SMN2 Exon 7
(A) SMN1: SRSF1 bound to the 50 end of the exon
(Cartegni et al., 2006; Cartegni and Krainer, 2002),
U2AF65 (Martins de Arau´jo et al., 2009), and
aTra2b complex (Cle´ry et al., 2011; Hofmann et al.,
2000) contribute to recruitment of U2 snRNP.
Green dotted lines show putative functional
interactions and may not correspond to direct
molecular contacts.
(B) SMN2: binding of hnRNP A1 and other proteins
(Kashima and Manley, 2003; Kashima et al.,
2007a, 2007b; Pedrotti et al., 2010) to various sites
are associated with loss of binding of SRSF1 and
U2AF (Martins de Arau´jo et al., 2009) and U2
recruitment.
(C) The AD of GGA permits some U2AF binding,
but U2 snRNP recruitment is weak.
(D) The GGA tail binds SRSF1when the quadruplex
is unwound, facilitating U2 recruitment inde-
pendently of Tra2b. Nonproductive complexes of
GGA with hnRNP F/H and in quadruplexes are also
shown. Weak base-pairing or protein binding may
enable rapid exchange of the various complexes on
SMN2 exon 7 until an SRSF1 complex is stabilized
by interactionswithotherproteinsor thepre-mRNA.dimers, in which tetrad-hexad quadruplexes are stacked
together, may reduce the sensitivity of the oligonucleotide to 50
nucleases. In addition, quadruplex formation is inimical to the
binding of proteins that bind single-stranded RNA (Samatanga
et al., 2013) andmay reduce the sequestration of splicing activa-
tors by free GGA in the cell. This may be a generally useful prop-
erty that could be exploited in the design of other functional
oligonucleotides.
The other predominant form of GGA appeared to be a complex
formed only with hnRNP F/H proteins, the binding of which
is incompatible with quadruplex formation (Samatanga et al.,
2013). SRSF1 complexes excluded nucleolin and DHX36 (Fig-
ure 4C) and thus are likely to also be in competition with quadru-
plexes. Overexpression of SRSF1 appeared to displace other
proteins (Figure 4D), suggesting that there are multiple binding
sites for SRSF1 on the ED, but that binding is not highly co-
operative (Eperon et al., 2000), allowing partial occupancy and
coexistence with other proteins. The coexistence of distinct
complexes is likely to be a general feature of ESEs and may
explain the common observation that SR proteins appear to be
at best minor components of complexes when proteins bound
to enhancers are analyzed after affinity purification (Staknis
and Reed, 1994; Dreumont et al., 2010).
Competition between hnRNP F/H and SRSF1 may not, within
limits, affect the efficacy of the oligonucleotide (Figures 4D
and 6D; Table S2). Moreover, TOES activity was reduced
by the use of SRSF1-binding sequences that would not bind
hnRNP H (Owen et al., 2011). It is possible that the various forms
of the oligonucleotide are in rapid equilibrium between pre-
mRNA-bound and free states, enabling the rapid exchange
of oligonucleotides in the quadruplex, hnRNP F/H, or SRSF1-
containing complexes. A requirement for rapid oligonucleotide
exchange would explain why increasing the strength of oligonu-
cleotide base-pairing to exon 7 reduced TOES activity (Owenet al., 2011). Alternatively, there might be a rapid exchange of
protein components bound to the oligonucleotide. Consistent
with the idea that SR proteins have only a transient association
with some enhancers are (1) the difficulties of demonstrating
that SR proteins are the predominant proteins bound to en-
hancers (Staknis and Reed, 1994; Dreumont et al., 2010), (2)
the inverse correlation found between SRSF2’s affinity for an
enhancer sequence and the activity of the enhancer (Dreumont
et al., 2010), (3) the poor correlation between the more highly
occupied SRSF1 and SRSF2 binding sites transcriptome-wide
and their effects on splicing (Pandit et al., 2013), and (4) the in-
crease in TOES activity with increased numbers of bindingmotifs
(Owen et al., 2011). Moreover, functional targets for SRSF1 are
more diverse than optimal binding sites, since half of them
have neither a GGA nor a GAA motif (Liu et al., 1998a; Smith
et al., 2006). The strength of binding of SRSF1 is likely to be
crucial in those cases where its activity requires only the second
RNA-binding domain, possibly because it displaces other
RNA-binding proteins (Cle´ry et al., 2013). For the majority of
enhancers, though, it may be that their activity does not depend
on the strength of their binding to SR proteins and instead is
based on fleeting ‘‘kiss and tell’’ encounters with SR proteins.EXPERIMENTAL PROCEDURES
In Vitro Splicing and Related Assays
Splicing assays were done in nuclear extract (Cilbiotech) as previously
described (Eperon and Krainer, 1994; Skordis et al., 2003). Complex formation
on exon-defined transcripts or pre-mRNA in the presence or absence of exog-
enous ATPwas analyzed as previously described (Das and Reed, 1999). Direct
crosslinking in nuclear extracts with short-wave UV light was done as previ-
ously described (Eperon et al., 2000) using RNA transcribed with [a-32P]
UTP. Immunoprecipitation after crosslinking and digestion with ribonucleases
A and T1 was done with an antibody to U2AF65 (Gama-Carvalho et al., 2006).
Psoralen-mediated crosslinking of RNA to snRNA and ribonuclease digestionCell Reports 9, 193–205, October 9, 2014 ª2014 The Authors 201
were performed as previously described (O’Mullane and Eperon, 1998). TOES
oligonucleotides were annealed to the RNA by incubation for 5 min at 80C in
50 mM potassium glutamate, 20 mM HEPES (pH 7.5), followed by gradual
cooling to 4C. GGA, ED, and AD oligonucleotides have been described else-
where (Owen et al., 2011). GSA-0820 andGSA-0902, dissolved in 10%DMSO,
were included at 1/10th volume in annealing reactions consisting of GGA
(500 nM), pre-mRNA, 100 mM potassium glutamate, and 40 mM HEPES
(pH 7.5) in silanized plasticware. Incubation was done for 10 min at 30C.
Splicing reactions were initiated by addition of an equal volume of the remain-
ing components and incubated at 30C for 2 hr. Knockdown of hnRNPs F
and H1 was done in HEK293T cells in 15 cm dishes. Knockdown of each
hnRNP was done using two siRNAs (s230280 and s6725 for hnRNP F,
and s6729 and s6730 for hnRNP H1; Ambion Life Technologies). Each
knockdown was done using three successive transfections at 10 mM with
Lipofectamine at intervals of 24 hr. Extracts were prepared as previously
described (Lee et al., 1988).
Affinity Purification and Analysis of Complexes on Oligonucleotides
For conventional biotin affinity purification (Figure 4A), RNA corresponding
to GGA was transcribed in the presence of biotin-11-UTP. Then 100 pmole
of RNA was selected on avidin-agarose beads and incubated for 10 min in
200 ml nuclear extract under splicing reaction conditions. The beads were
washed four times with 600 ml of ice-cold FSP buffer (20 mM Tris-HCl
[pH 7.5], 60 mM KCl, 2.5 mM EDTA, 0.1% NP40) and once with FSP buffer
without KCl, and bound proteins were eluted with a solution containing 2%
SDS and 20 mM dithiothreitol. The GGA-PC-Bio oligonucleotide was synthe-
sized by DNA Technology. For the purification of complexes, GGA-PC-Bio
was incubated in nuclear extract in darkness and then the mixture was
captured by incubation for 2–12 hr at 4C with NeutrAvidin agarose (Thermo
Scientific). After washing with 100 mM NaPO4 [pH 7.2], 150 mM NaCl,
0.05% NP-40, and then 100 mM NaPO4 [pH 7.2], 0.05% NP-40, the oligonu-
cleotide was cleaved between the ED and AD by irradiation of moist beads
with broad-range UV (UVP Bio-Lite) for 2.5 min. The ED complex was recov-
ered by elution with 100 mM NaPO4 [pH 7.2], 0.05% NP-40. Irradiation and
elution were repeated thrice. Analysis by MS is described in the Supplemental
Experimental Procedures. Crosslinking of GGA to associated proteins was
done in two ways. In one, a p-azidotetrafluorobenzoic moiety was conjugated
to the 50 phosphate group of the 32P-labeled GGA RNA via an ethylenediamine
spacer as previously described (Malygin et al., 1999). After incubation of
the RNA derivative (20 pmol) in 40 ml of nuclear extract under splicing reaction
conditions and irradiation with long-wave UV light (>300 nm), the reaction
mixture was treated with RNase A and analyzed by SDS-PAGE. Alternatively,
the GGA or ED was 50 end-labeled with 32P, incubated in nuclear extracts
prepared as previously described (Hodson et al., 2012), irradiated with
short-wave UV light, and subjected to SDS-PAGE. Immunoprecipitation prior
to electrophoresis was done with an antibody to SRSF1 (Hanamura et al.,
1998) or hnRNP F/H (Abcam ab10689). The structural analysis of the oligo-
nucleotides is described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.08.051.
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